NCT02414139 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 54
- group Id
- BG003
- value
- 30
- group Id
- BG004
- value
- 69
- group Id
- BG005
- value
- 15
- group Id
- BG006
- value
- 28
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 31
- group Id
- BG009
- value
- 32
- group Id
- BG010
- value
- 373
- units
- Participants
- groups
- description
- Pre-treated patients with MET GCN ≥ 10 treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG000
- title
- Cohort 1a: Pre-treated Patients With MET GCN ≥ 10 (2/3L)
- description
- Pre-treated patients with MET GCN ≥ 6 and \< 10 treated with INC280 at 400 mg BID as second or third line (2/3L)
- id
- BG001
- title
- Cohort 1b: Pre-treated Patients With MET GCN ≥ 6 and < 10 (2/3L)
- description
- Pre-treated patients with MET GCN ≥ 4 and \< 6 treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG002
- title
- Cohort 2: Pre-treated Patients With MET GCN ≥ 4 and < 6 (2/3L)
- description
- Pre-treated patients with MET GCN \< 4 treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG003
- title
- Cohort 3: Pre-treated Patients With MET GCN < 4 (2/3L)
- description
- Pre-treated patients with MET mutation regardless of MET GCN treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG004
- title
- Cohort 4: Pre-treated Patients With MET Mutation Regardless of MET GCN (2/3L)
- description
- Treatment-naïve patients with MET GCN ≥10 treated with INC280 at 400mg BID as first-line (1L)
- id
- BG005
- title
- Cohort 5a: Treatment-naïve Patients With MET GCN ≥10 (1L)
- description
- Treatment-naïve patients with MET mutation regardless of MET GCN treated with INC280 at 400mg BID as first line (1L)
- id
- BG006
- title
- Cohort 5b: Treatment-naïve Patients With MET Mutation Regardless of MET GCN (1L)
- description
- Pre-treated patients with MET GCN ≥ 10 without MET mutation treated with INC280 at 400 mg BID as second line (2L) (expansion cohort of Cohort 1a)
- id
- BG007
- title
- Cohort 6.1 (Expansion of Cohort 1a): Pre-treated Patients MET GCN ≥ 10 Without MET Mutation (2L)
- description
- Pre-treated patients with MET mutation regardless of MET GCN treated with INC280 at 400 mg BID as second line (2L)(expansion of Cohort 4)
- id
- BG008
- title
- Cohort 6.2 (Expansion of Cohort 4): Pre-treated Patients With MET Mutation (2L)
- description
- Treatment-naïve patients with MET mutation regardless of MET GCN treated with INC280 at 400mg BID as first line (1L) (expansion cohort of Cohort 5b)
- id
- BG009
- title
- Cohort 7 (Expansion of Cohort 5b): Treatment-naïve With MET Mutation Regardless of MET GCN (1L)
- description
- Total of all reporting groups
- id
- BG010
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.56
- value
- 60.9
- group Id
- BG001
- spread
- 9.11
- value
- 59.5
- group Id
- BG002
- spread
- 10.00
- value
- 61.7
- group Id
- BG003
- spread
- 9.23
- value
- 61.7
- group Id
- BG004
- spread
- 8.32
- value
- 71.0
- group Id
- BG005
- spread
- 10.36
- value
- 68.2
- group Id
- BG006
- spread
- 7.02
- value
- 72.4
- group Id
- BG007
- spread
- 10.69
- value
- 60.7
- group Id
- BG008
- spread
- 6.29
- value
- 69.0
- group Id
- BG009
- spread
- 8.35
- value
- 73.3
- group Id
- BG010
- spread
- 10.18
- value
- 65.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 40
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 18
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 16
- group Id
- BG009
- value
- 23
- group Id
- BG010
- value
- 164
- title
- Female
- measurements
- group Id
- BG000
- value
- 54
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 29
- group Id
- BG005
- value
- 11
- group Id
- BG006
- value
- 10
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 15
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 209
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 19
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 84
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 3
- title
- Black
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 49
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 24
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 24
- group Id
- BG009
- value
- 26
- group Id
- BG010
- value
- 281
- title
- Caucasian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 2
- title
- Native American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 1
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 2
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 42
- group Id
- BG002
- value
- 54
- group Id
- BG003
- value
- 30
- group Id
- BG004
- value
- 69
- group Id
- BG005
- value
- 15
- group Id
- BG006
- value
- 28
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 31
- group Id
- BG009
- value
- 32
- group Id
- BG010
- value
- 373
- units
- Participants
- groups
- description
- Pre-treated patients with MET GCN ≥ 10 treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG000
- title
- Cohort 1a: Pre-treated Patients With MET GCN ≥ 10 (2/3L)
- description
- Pre-treated patients with MET GCN ≥ 6 and \< 10 treated with INC280 at 400 mg BID as second or third line (2/3L)
- id
- BG001
- title
- Cohort 1b: Pre-treated Patients With MET GCN ≥ 6 and < 10 (2/3L)
- description
- Pre-treated patients with MET GCN ≥ 4 and \< 6 treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG002
- title
- Cohort 2: Pre-treated Patients With MET GCN ≥ 4 and < 6 (2/3L)
- description
- Pre-treated patients with MET GCN \< 4 treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG003
- title
- Cohort 3: Pre-treated Patients With MET GCN < 4 (2/3L)
- description
- Pre-treated patients with MET mutation regardless of MET GCN treated with INC280 at 400mg BID as second or third line (2/3L)
- id
- BG004
- title
- Cohort 4: Pre-treated Patients With MET Mutation Regardless of MET GCN (2/3L)
- description
- Treatment-naïve patients with MET GCN ≥10 treated with INC280 at 400mg BID as first-line (1L)
- id
- BG005
- title
- Cohort 5a: Treatment-naïve Patients With MET GCN ≥10 (1L)
- description
- Treatment-naïve patients with MET mutation regardless of MET GCN treated with INC280 at 400mg BID as first line (1L)
- id
- BG006
- title
- Cohort 5b: Treatment-naïve Patients With MET Mutation Regardless of MET GCN (1L)
- description
- Pre-treated patients with MET GCN ≥ 10 without MET mutation treated with INC280 at 400 mg BID as second line (2L) (expansion cohort of Cohort 1a)
- id
- BG007
- title
- Cohort 6.1 (Expansion of Cohort 1a): Pre-treated Patients MET GCN ≥ 10 Without MET Mutation (2L)
- description
- Pre-treated patients with MET mutation regardless of MET GCN treated with INC280 at 400 mg BID as second line (2L)(expansion of Cohort 4)
- id
- BG008
- title
- Cohort 6.2 (Expansion of Cohort 4): Pre-treated Patients With MET Mutation (2L)
- description
- Treatment-naïve patients with MET mutation regardless of MET GCN treated with INC280 at 400mg BID as first line (1L) (expansion cohort of Cohort 5b)
- id
- BG009
- title
- Cohort 7 (Expansion of Cohort 5b): Treatment-naïve With MET Mutation Regardless of MET GCN (1L)
- description
- Total of all reporting groups
- id
- BG010
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.56
- value
- 60.9
- group Id
- BG001
- spread
- 9.11
- value
- 59.5
- group Id
- BG002
- spread
- 10.00
- value
- 61.7
- group Id
- BG003
- spread
- 9.23
- value
- 61.7
- group Id
- BG004
- spread
- 8.32
- value
- 71.0
- group Id
- BG005
- spread
- 10.36
- value
- 68.2
- group Id
- BG006
- spread
- 7.02
- value
- 72.4
- group Id
- BG007
- spread
- 10.69
- value
- 60.7
- group Id
- BG008
- spread
- 6.29
- value
- 69.0
- group Id
- BG009
- spread
- 8.35
- value
- 73.3
- group Id
- BG010
- spread
- 10.18
- value
- 65.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 40
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 18
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 16
- group Id
- BG009
- value
- 23
- group Id
- BG010
- value
- 164
- title
- Female
- measurements
- group Id
- BG000
- value
- 54
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 29
- group Id
- BG005
- value
- 11
- group Id
- BG006
- value
- 10
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 15
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 209
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 19
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 84
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 3
- title
- Black
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 38
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 19
- group Id
- BG004
- value
- 49
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 24
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 24
- group Id
- BG009
- value
- 26
- group Id
- BG010
- value
- 281
- title
- Caucasian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 2
- title
- Native American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 1
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 2
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle